Related Experiment Video
Updated: Aug 30, 2025

06:28
Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization
Published on: June 4, 2020
6.9K
Rotational Thromboelastometry Predicts Transfusion Requirements in Total Joint Arthroplasties
Andreas G Tsantes1, Dimitrios V Papadopoulos2, Anastasios G Roustemis3
1Laboratory of Haematology and Blood Bank Unit, "Attiko" Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Seminars in Thrombosis and Hemostasis
|September 2, 2022
Summary
Rotational thromboelastometry (ROTEM) effectively predicts red blood cell (RBC) transfusion needs and bleeding risk in joint replacement surgery. Higher postoperative FIBTEM maximum clot firmness indicates a lower risk of transfusion and bleeding.
Area of Science:
- Anesthesiology and Perioperative Medicine
- Hematology and Coagulation Science
- Orthopedic Surgery
Background:
- Red blood cell (RBC) transfusions are common in total joint arthroplasties (TJA).
- Hemorrhagic risk in TJA is influenced by surgical and patient factors.
- Predictive tools for transfusion and bleeding are crucial for patient management.
Purpose of the Study:
- To evaluate the utility of rotational thromboelastometry (ROTEM) in identifying patients at high risk for transfusion and excessive bleeding after TJA.
- To correlate ROTEM parameters with transfusion requirements and postoperative blood loss.
Main Methods:
- Prospective observational study of 206 patients undergoing total knee or hip arthroplasty.
- Preoperative and postoperative coagulation status assessed using ROTEM and conventional tests.
- Recorded RBC transfusions and postoperative hemoglobin drop.
Main Results:
- Higher postoperative FIBTEM maximum clot firmness (MCF) correlated with reduced risk of transfusion (OR: 0.66) and excessive bleeding (OR: 0.58).
- Postoperative FIBTEM MCF ≤10mm showed 80.1% sensitivity and 75.5% specificity for predicting transfusion.
- ROTEM demonstrated high predictive accuracy for transfusion and bleeding, with an 86.3% transfusion probability for FIBTEM MCF 0-4mm.
Conclusions:
- ROTEM is a valuable tool for predicting transfusion requirements and excessive bleeding in TJA patients.
- Early identification of high-risk patients enables proactive blood bank management and targeted blood-saving strategies.
- FIBTEM MCF is a key parameter for risk stratification in perioperative coagulation management.

